AU2002227496A8 - Polynucleotides and polypeptides - Google Patents

Polynucleotides and polypeptides

Info

Publication number
AU2002227496A8
AU2002227496A8 AU2002227496A AU2002227496A AU2002227496A8 AU 2002227496 A8 AU2002227496 A8 AU 2002227496A8 AU 2002227496 A AU2002227496 A AU 2002227496A AU 2002227496 A AU2002227496 A AU 2002227496A AU 2002227496 A8 AU2002227496 A8 AU 2002227496A8
Authority
AU
Australia
Prior art keywords
polynucleotides
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002227496A
Inventor
Raymond Anthony Jupp
Ian Mcdonald Hayes
William Kenneth Pollack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0018700A external-priority patent/GB0018700D0/en
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Publication of AU2002227496A8 publication Critical patent/AU2002227496A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002227496A 2000-07-31 2001-07-30 Polynucleotides and polypeptides Abandoned AU2002227496A8 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018700A GB0018700D0 (en) 2000-07-31 2000-07-31 Polynucleotides and polypeptides
GB0031021A GB0031021D0 (en) 2000-07-31 2000-12-19 Polynucleotides and polypeptides
PCT/GB2001/003390 WO2002010198A2 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides

Publications (1)

Publication Number Publication Date
AU2002227496A8 true AU2002227496A8 (en) 2007-12-20

Family

ID=26244763

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002227496A Abandoned AU2002227496A1 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides
AU2002227496A Abandoned AU2002227496A8 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2002227496A Abandoned AU2002227496A1 (en) 2000-07-31 2001-07-30 Polynucleotides and polypeptides

Country Status (3)

Country Link
AU (2) AU2002227496A1 (en)
GB (1) GB0031021D0 (en)
WO (1) WO2002010198A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60135232D1 (en) 2000-08-28 2008-09-18 Agensys Inc NUCLEIC ACID AND CORRESPONDING PROTEIN 85P1B3, USEFUL FOR THE TREATMENT AND DETECTION OF CANCER DISORDERS
WO2021248053A2 (en) * 2020-06-04 2021-12-09 Godx, Inc. Point-of-care sars-cov-2 virus diagnostic device and methods of use thereof

Also Published As

Publication number Publication date
WO2002010198A3 (en) 2007-10-18
AU2002227496A1 (en) 2002-02-13
GB0031021D0 (en) 2001-01-31
WO2002010198A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
HUP0500989A2 (en) Animicrobial polypeptides and their uses
IL153568A (en) Novel polypeptides and polynucleotides
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
AU2001265009A1 (en) Human polynucleotides and polypeptides encoded thereby
EP1183344A4 (en) Adam polynucleotides and polypeptides
EP1252333A4 (en) Methods and materials relating to cd84-like polypeptides and polynucleotides
EP1049708A4 (en) Meth1 and meth2 polynucleotides and polypeptides
EP1409661A4 (en) Hdac9 polypeptides and polynucleotides and uses thereof
EP1254266A4 (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
AU2001280608A1 (en) Human polynucleotides and polypeptides encoded thereby
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
AU2002227496A8 (en) Polynucleotides and polypeptides
GB0112941D0 (en) Sbg FGF-9A Polynucleotides and polypeptides
AU3486501A (en) Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
EP1248801A4 (en) Human polynucleotides, polypeptides, and antibodies
GB0004561D0 (en) Polynucleotides and polypeptides
GB0018700D0 (en) Polynucleotides and polypeptides
AU6534301A (en) Phosphorylated polypeptides and uses related thereto
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
GB0018307D0 (en) Polypeptides
EP1254265A4 (en) Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides
GB9922243D0 (en) Polynucleotides and polypeptides
GB0113257D0 (en) Polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase